Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6G97

Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2

Experimental procedure
Experimental methodSINGLE WAVELENGTH
Source typeROTATING ANODE
Source detailsRIGAKU FR-X
Temperature [K]100
Detector technologyPIXEL
Collection date2015-02-10
DetectorDECTRIS PILATUS 300K
Wavelength(s)1.54178
Spacegroup nameP 1 21 1
Unit cell lengths49.023, 70.399, 61.624
Unit cell angles90.00, 112.39, 90.00
Refinement procedure
Resolution45.330 - 1.900
R-factor0.164
Rwork0.160
R-free0.22300
Structure solution methodFOURIER SYNTHESIS
RMSD bond length0.013
RMSD bond angle1.110
Data reduction softwareXDS
Data scaling softwareAimless
Phasing softwareBUSTER
Refinement softwareBUSTER (2.11.7)
Data quality characteristics
 OverallOuter shell
Low resolution limit [Å]45.3301.940
High resolution limit [Å]1.9001.900
Rmerge0.863
Rmeas0.062
Number of reflections305401576
<I/σ(I)>12
Completeness [%]98.191.6
Redundancy2.8
Crystallization Conditions
crystal IDmethodpHtemperaturedetails
1VAPOR DIFFUSION, SITTING DROP7.22930.3M (NH4)2SO4, 32.0%w/v MPEG 2000, 0.1M HEPES/NaOHpH=7.2, 0.02M Mercaptoethanol

219869

PDB entries from 2024-05-15

PDB statisticsPDBj update infoContact PDBjnumon